⌘K

Login Start Free

Home/Filings/4/0001062993-25-005645

4//SEC Filing

PISKEL KYLE 4

Accession 0001062993-25-005645

CIK 0001478320other

View on SEC.gov Company Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 7:34 PM ET

Size

6.7 KB

Accession

0001062993-25-005645

Insider Transaction Report

Form 4

Period: 2025-03-14

Adaptive Biotechnologies CorpADPT

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2025-03-14$6.32/sh+2,500$15,800→ 271,510 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-03-14−2,500→ 0 total
Exercise: $6.32Exp: 2026-11-08→ Common Stock (2,500 underlying)

Footnotes (1)

[F1]The option was fully vested and exercisable.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Adaptive Biotechnologies Corp

CIK 0001478320

Entity typeother

Related Parties

1

filerCIK 0001780662

Filing Metadata

Form type: 4
Filed: Mar 16, 8:00 PM ET
Accepted: Mar 17, 7:34 PM ET
Size: 6.7 KB

View on SEC.gov